Awards as PI
Award Value
Early Translational III Stem cell based small molecule therapy for Alzheimer's disease $1,673,757
Preclinical Development Awards Human Stem-Cell Based Development of a Potent Alzheimer’s Drug Candidate $1,664,885
Total:
$3,338,642.00